The influence of genetic polymorphisms and interacting drugs on initial response to warfarin in Chinese patients with heart valve replacement

被引：0
|
作者：
Shi-Long Zhong
Yuan Liu
Xi-Yong Yu
Dan Xu
Hong-Hong Tan
Qiu-Xiong Lin
Min Yang
Hai-Yan Lao
Shu-Guang Lin
机构：
[1] Guangdong Provincial Cardiovascular Institute,
[2] Medical Research Center of Guangdong General Hospital,undefined
[3] Guangdong Institute of Clinical Pharmacology,undefined
[4] Guangdong Academy of Medical Sciences,undefined
来源：
European Journal of Clinical Pharmacology | 2011年 / 67卷
关键词：
Warfarin; Initial response; Drug interaction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：581 / 590
页数：9
相关论文
共 50 条
  • [31] Management of the initial phase of warfarin treatment: Retrospective analysis of post-operative heart valve replacement patients compared with nonsurgical patients.
    Ageno, W
    Johnson, J
    Nowacki, B
    Siguenza, M
    Turpie, AGG
    BLOOD, 1997, 90 (10) : 3199 - 3199
  • [32] Verification of Pharmacogenetics-Based Warfarin Dosing Algorithms in Han-Chinese Patients Undertaking Mechanic Heart Valve Replacement
    Zhao, Li
    Chen, Chunxia
    Li, Bei
    Dong, Li
    Guo, Yingqiang
    Xiao, Xijun
    Zhang, Eryong
    Qin, Li
    PLOS ONE, 2014, 9 (04):
  • [33] A COMPARISON OF ASPIRIN WITH PLACEBO IN PATIENTS TREATED WITH WARFARIN AFTER HEART-VALVE REPLACEMENT
    TURPIE, AGG
    GENT, M
    LAUPACIS, A
    LATOUR, Y
    GUNSTENSEN, J
    BASILE, F
    KLIMEK, M
    HIRSH, J
    NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (08): : 524 - 529
  • [34] The Influence of CYP2C9 and VKORC1 Gene Polymorphisms on Optimal Warfarin Doses After Heart Valve Replacement
    Tatarunas, Vacis
    Lesauskaite, Vaiva
    Veikutiene, Audrone
    Jakuska, Povilas
    Benetis, Rimantas
    MEDICINA-LITHUANIA, 2011, 47 (01): : 25 - 30
  • [35] Cytochrome P450 oxidoreductase genetic polymorphisms A503V and rs2868177 do not significantly affect warfarin stable dosage in Han-Chinese patients with mechanical heart valve replacement
    Tan, Sheng-Lan
    Li, Zhi
    Zhang, Wei
    Song, Guo-Bao
    Liu, Li-Ming
    Peng, Juan
    Liu, Zhao-Qian
    Fan, Lan
    Meng, Xiang-Guang
    Wang, Lian-Sheng
    Chen, Yao
    Zhou, Xin-Min
    Zhou, Hong-Hao
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (10) : 1769 - 1775
  • [36] Cytochrome P450 oxidoreductase genetic polymorphisms A503V and rs2868177 do not significantly affect warfarin stable dosage in Han-Chinese patients with mechanical heart valve replacement
    Sheng-Lan Tan
    Zhi Li
    Wei Zhang
    Guo-Bao Song
    Li-Ming Liu
    Juan Peng
    Zhao-Qian Liu
    Lan Fan
    Xiang-Guang Meng
    Lian-Sheng Wang
    Yao Chen
    Xin-Min Zhou
    Hong-Hao Zhou
    European Journal of Clinical Pharmacology, 2013, 69 : 1769 - 1775
  • [37] CYP4F2 rs2108622: a minor significant genetic factor of warfarin dose in Han Chinese patients with mechanical heart valve replacement
    Cen, Han-Jing
    Zeng, Wu-Tao
    Leng, Xiu-Yu
    Huang, Min
    Chen, Xiao
    Li, Jia-Li
    Huang, Zhi-Ying
    Bi, Hui-Chang
    Wang, Xue-Ding
    He, Yan-Ling
    He, Fan
    Zhou, Rui-Na
    Zheng, Qi-Shan
    Zhao, Li-Zi
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 70 (02) : 234 - 240
  • [38] Efficacy of human prothrombin complex concentrate in the treatment of warfarin overdose in patients receiving warfarin for mechanical heart valve replacement
    Uncu, Hasan
    Badak, Tolga Onur
    Ucak, Haci Ali
    Cereb, Ferid
    Cakallioglu, Ahmet
    MEDICINE, 2024, 103 (19) : E38022
  • [39] Effect of NPC1L1 polymorphism on warfarin stable dose in Chinese patients under heart valve replacement surgery
    Ma, Siqing
    Luo, Zhiying
    Zhou, Xinmin
    Zhou, Honghao
    Chen, Ling
    Zhang, Wei
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2022, 49 (02) : 212 - 218
  • [40] Genetic influence on bleeding and over-anticoagulation risk in patients undergoing warfarin treatment after heart valve replacements
    Zhou, Ling
    Ding, Yinglong
    Gao, Yuan
    Yang, Biwen
    Bao, Jianan
    Ma, Jingjing
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2020, 16 (01) : 1 - 9
12345